Streptozocine [Inn-French] en es it fr

Streptozocine [Inn-French] Brand names, Streptozocine [Inn-French] Analogs

Streptozocine [Inn-French] Brand Names Mixture

  • No information avaliable

Streptozocine [Inn-French] Chemical_Formula

C8H15N3O7

Streptozocine [Inn-French] RX_link

http://www.rxlist.com/cgi/generic/zanosar.htm

Streptozocine [Inn-French] fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=215

Streptozocine [Inn-French] msds (material safety sheet)

Streptozocine [Inn-French] Synthesis Reference

No information avaliable

Streptozocine [Inn-French] Molecular Weight

265.221 g/mol

Streptozocine [Inn-French] Melting Point

115 oC

Streptozocine [Inn-French] H2O Solubility

5070 mg/L

Streptozocine [Inn-French] State

Solid

Streptozocine [Inn-French] LogP

-2.958

Streptozocine [Inn-French] Dosage Forms

Powder for solution

Streptozocine [Inn-French] Indication

For the treatment of malignant neoplasms of pancreas (metastatic islet cell carcinoma).

Streptozocine [Inn-French] Pharmacology

Streptozocin is an antitumour antibiotic consisting of a nitrosourea moiety interposed between a methyl group and a glucosamine. Streptozocin is indicated in the treatment of metastatic islet cell carcinoma of the pancreas. Streptozocin inhibits DNA synthesis in bacterial and mammalian cells. In bacterial cells, a specific interaction with cytosine moieties leads to degradation of DNA. The biochemical mechanism leading to mammalian cell death has not been definitely established; streptozocin inhibits cell proliferation at a considerably lower level than that needed to inhibit precursor incorporation into DNA or to inhibit several of the enzymes involved in DNA synthesis. Although streptozocin inhibits the progression of cells into mitosis, no specific phase of the cell cycle is particularly sensitive to its lethal effects.

Streptozocine [Inn-French] Absorption

Poor oral absorption (17-25%)

Streptozocine [Inn-French] side effects and Toxicity

Symptoms of overdose include nausea and vomiting, anorexia, myelosuppression; and nephrotoxicity.

Streptozocine [Inn-French] Patient Information

No information avaliable

Streptozocine [Inn-French] Organisms Affected

Humans and other mammals